Page 15
licensed to operate in the state upon a determination by the council that such an arrangement would be in the public interest and the likelihood of the success of the loan is great. Section 6. Subsection (2) of section 381.0031, Florida Statutes, is amended to read: 381.0031 Epidemiological research; report of diseases of public health significance to department.— (2) Any practitioner licensed in this state to practice medicine, osteopathic medicine, chiropractic medicine, naturopathy, or veterinary medicine; any hospital licensed under part I of chapter 395; or any laboratory appropriately certified by the Centers for Medicare and Medicaid Services under the federal Clinical Laboratory Improvement Amendments and the federal rules adopted thereunder which licensed under chapter 483 that diagnoses or suspects the existence of a disease of public health significance shall immediately report the fact to the Department of Health. Section 7. Subsection (3) of section 381.0034, Florida Statutes, is amended to read: Ch. 2018-24 LAWS OF FLORIDA Ch. 2018-24 8 CODING: Words stricken are deletions; words underlined are additions. 381.0034 Requirement for instruction on HIV and AIDS.— (3) The department shall require, as a condition of granting a license under chapter 467 or part II III of chapter 483, that an applicant making initial application for licensure complete an educational course acceptable to the department on human immunodeficiency virus and acquired immune deficiency syndrome. Upon submission of an affidavit showing good cause, an applicant who has not taken a course at the time of licensure shall be allowed 6 months to complete this requirement. Section 8. Paragraph (c) of subsection (4) of section 381.004, Florida Statutes, is amended to read: 381.004 HIV testing.— (4) HUMAN IMMUNODEFICIENCY VIRUS TESTING REQUIREMENTS; REGISTRATION WITH THE DEPARTMENT OF HEALTH; EXEMPTIONS FROM REGISTRATION.—No county health department and no other person in this state shall conduct or hold themselves out to the public as conducting a testing program for acquired immune deficiency syndrome or human immunodeficiency virus status without first registering with the Department of Health, reregistering each year, complying with all other applicable provisions of state law, and meeting the following requirements: (c) The program shall have all laboratory procedures performed in a laboratory appropriately certified by the Centers for Medicare and Medicaid Services under the federal Clinical Laboratory Improvement Amendments and the federal rules adopted thereunder licensed under the provisions of chapter 483. Section 9. Paragraph (f) of subsection (4) of section 381.0405, Florida Statutes, is amended to read: 381.0405 Office of Rural Health.— (4) COORDINATION.—The office shall: (f) Assume responsibility for state coordination of the Rural Hospital Transition Grant Program, the Essential Access Community Hospital Program, and other federal rural health care programs. Section 10. Paragraph (c) of subsection (4) of section 381.915, Florida Statutes, is amended to read: 381.915 Florida Consortium of National Cancer Institute Centers Program.— (4) Tier designations and corresponding weights within the Florida Consortium of National Cancer Institute Centers Program are as follows: Ch. 2018-24 LAWS OF FLORIDA Ch. 2018-24 9 CODING: Words stricken are deletions; words underlined are additions. (c) Tier 3: Florida-based cancer centers seeking designation as either a NCI-designated cancer center or NCI-designated comprehensive cancer center, which shall be weighted at 1.0. 1. A cancer center shall meet the following minimum criteria to be considered eligible for Tier 3 designation in any given fiscal year: a. Conducting cancer-related basic scientific research and cancer-related population scientific research; b. Offering and providing the full range of diagnostic and treatment services on site, as determined by the Commission on Cancer of the American College of Surgeons; c. Hosting or conducting cancer-related interventional clinical trials that are registered with the NCI’s Clinical Trials Reporting Program; d. Offering degree-granting programs or